Liquidia Technologies, Inc. (LQDA)


Liquidia Technologies, Inc. (LQDA)

$8.68 USD

0.04 (0.46%)

Updated Jun 17 6:55pm

Add LQDA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 207 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

LQDA Daily Price Range
LQDA 52-Week Price Range

LQDA News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All LQDA News

Liquidia Technologies, Inc. (LQDA) Company Bio


Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.

LQDA Stock Chart More Charts


LQDA Price/Volume Stats

Current price $8.68
Prev. close $8.64
Day low $8.57
Day high $8.88
50-day MA $9.47
200-day MA $16.99
52-week high $38.46
52-week low $8.01
Volume 40,300
Avg. volume 92,548
Dividend yield N/A
Market Cap 161.82M

LQDA Social Stream


Loading social stream, please wait...

View Full LQDA Social Stream

LQDA Returns

1-mo -11.43%
3-mo -36.60%
6-mo -57.16%
1-year N/A
3-year N/A
5-year N/A
YTD -59.93%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
Page generated in 0.3561 seconds.